ABMT (Advanced BioMedical Technologies) Shares Outstanding (EOP): 70.23 Mil (As of Jul. 2021)


What is Advanced BioMedical Technologies Shares Outstanding (EOP)?

Advanced BioMedical Technologies ABMT Shares Outstanding (EOP) is 70.23 Mil as of Jul. 2021.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Advanced BioMedical Technologies's shares outstanding for the quarter that ended in Jul. 2021 was 70.23 Mil.

Advanced BioMedical Technologies's quarterly shares outstanding stayed the same from Apr. 2021 (70.23 Mil) to Jul. 2021 (70.23 Mil).

Advanced BioMedical Technologies's annual shares outstanding increased from Oct. 2019 (69.88 Mil) to Oct. 2020 (70.23 Mil). It means Advanced BioMedical Technologies issued new shares from Oct. 2019 to Oct. 2020 .


Advanced BioMedical Technologies  (OTCPK:ABMT) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Advanced BioMedical Technologies Shares Outstanding (EOP) Related Terms


Advanced BioMedical Technologies Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Advanced BioMedical Technologies's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Advanced BioMedical Technologies Shares Outstanding (EOP) Chart

Advanced BioMedical Technologies Annual Data
Trend Oct11 Oct12 Oct13 Oct14 Oct15 Oct16 Oct17 Oct18 Oct19 Oct20
Shares Outstanding (EOP)
Get a 7-Day Free Trial Premium Member Only Premium Member Only 67.13 69.38 69.63 69.88 70.23

Advanced BioMedical Technologies Quarterly Data
Oct16 Jan17 Apr17 Jul17 Oct17 Jan18 Apr18 Jul18 Oct18 Jan19 Apr19 Jul19 Oct19 Jan20 Apr20 Jul20 Oct20 Jan21 Apr21 Jul21
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 69.98 70.23 70.23 70.23 70.23

ABMT vs VYCO, ADMT, THMO: Shares Outstanding (EOP) Comparison

For the Medical Devices subindustry, Advanced BioMedical Technologies's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Advanced BioMedical Technologies Shares Outstanding (EOP) vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Advanced BioMedical Technologies's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Advanced BioMedical Technologies's Shares Outstanding (EOP) falls into.



Advanced BioMedical Technologies Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 70.23 Mil mean?
Advanced BioMedical Technologies (ABMT) has a Shares Outstanding (EOP) of 70.23 Mil as of Jul. 2021. The total shares a company has outstanding, at period-end. View historical data on Advanced BioMedical Technologies and its competitors.
Is Advanced BioMedical Technologies' Shares Outstanding (EOP) too high?
Advanced BioMedical Technologies' current Shares Outstanding (EOP) is 70.23 Mil.
How does Advanced BioMedical Technologies' Shares Outstanding (EOP) compare to VYCO and ADMT?
Advanced BioMedical Technologies' Shares Outstanding (EOP) of 70.23 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Medical Devices & Instruments company?
A good Shares Outstanding (EOP) depends on the Medical Devices & Instruments industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Advanced BioMedical Technologies and its competitors. Advanced BioMedical Technologies's current Shares Outstanding (EOP) is 70.23 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Advanced BioMedical Technologies stock overvalued right now?
Advanced BioMedical Technologies (ABMT) has a current Shares Outstanding (EOP) of 70.23 Mil. The current Shares Outstanding (EOP) is 70.23 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Advanced BioMedical Technologies (ABMT), the current Shares Outstanding (EOP) is 70.23 Mil as of Jul. 2021. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Advanced BioMedical Technologies Business Description

Address 535 Fifth Avenue, 4th Floor, New York, NY, USA, 10017
Advanced BioMedical Technologies Inc is engaged in designing, developing, manufacturing, and the planned future marketing of self-reinforced, re-absorbable, biodegradable internal fixation devices. The company manufactures its products using Polyamide, and it is used in a variety of applications, which include orthopaedic trauma, sports-related medical treatment, cartilage injuries, and reconstructive dental procedures. Its Polyamide products include screws, rods, and binding wires consisting of enhanced fibres and high molecular polymers, which are designed to facilitate quick healing of complex fractures in many areas of the human skeletal system.